gebhart/patrepeval huggingface dataset:
Importance and Relevance of Melatonin to Human Biological Rhythms (2003)

The pineal hormone melatonin is a remarkable molecule, with a conserved time-keeping function across species. It is extensively used as a self-administered remedy for sleep disturbance in countries where it is freely available, and to some extent when it is available on prescription, as in the UK. In some circumstances, notably free-running sleep disorder of the blind, it is the treatment of choice. It is also the marker rhythm of choice for the determination of circadian phase and period. This review outlines the current state of knowledge within a physiological perspective with emphasis on human biological rhythms.
Novel Modified Carboxy Terminal Fragments of Neuropeptide Y with High Affinity for Y2-Type Receptors and Potent Functional Antagonism at the Y1-Type Receptor (1995)

Peptide analogs of neuropeptide Y (NPY) with a Tyr-32 and Leu-34 replacement resulted in the decapeptide TyrIleAsnLeuIleTyrArgLeuArgTyr-NH2 (9; Table 1) and a 3700-fold improvement in affinity at Y2 (rat brain; IC50 = 8.2 +/- 3 nM) receptors when compared to the native NPY(27-36) C-terminal fragment. In addition, compound 9 was an agonist at Y1 (human erythroleukemia (HEL) cell; ED50 = 8.8 +/- 0.5 nM) receptors with potency comparable to that of NPY(1-36) (ED50 = 5 nM). Molecular dynamics and 1H-NMR were used to propose a solution structure of decapeptide 9 and for subsequent analog design. The replacement of Leu with Pro at position 4 of decapeptide 9 afforded an antagonist of NPY in HEL cells (18, TyrIleAsnProIleTyrArgLeuArgTyr-NH2; IC50 = 100 +/- 5 nM). Deletion of the N-terminal tyrosine of 18 resulted in a 10-fold improvement in antagonistic activity with a parallel 4-fold decrease in Y2 affinity. This potent antagonist may provide further insight into the physiological role(s) for NPY in the mammalian and peripheral nervous system.
The effectiveness and cost-effectiveness of prophylactic removal of wisdom teeth. (2000)

Forty studies were included in the review: two RCTs, 34 literature reviews, and four decision analysis studies. One RCT in the UK focused on the effects of retained third molars on incisor crowding (predominantly a cosmetic problem) in patients who had previously undergone orthodontic treatment. The results of this trial suggested that the removal of third molars to prevent late incisor crowding cannot be justified. Another on-going RCT in Denmark compares the effects and costs of prophylactic removal of third molars with removal according to morbidity. So far, this trial has recruited 200 participants, and preliminary results indicate that watchful waiting may be a promising strategy. However, more data and longer follow-up of patients are needed to conclude which treatment strategy is the most cost-effective. It is also known that a trial is on-going in the USA but no results are available so far. The methodological quality of the literature reviews was generally poor, and none of the reviews was systematic. Conclusions from nine reviews on anterior crowding suggested that there was only a weak association between retention of third molars and crowding. Six out of 21 reviews with a more general scope also concluded that the prophylactic removal of third molars was unjustified. Twelve general reviews did not conclude with a clear message about the management of third molars. Three reviews suggested that prophylactic removal of third molars is appropriate, but these reviews were of poorer methodological quality than the majority of other reviews. Three out of four papers focusing on surgical management expressed
A reconfigurable computing architecture for implementing artificial neural networks on FPGA (2003)

Artificial Neural Networks (ANNs), and the backpropagation algorithm in particular, is a form of artificial intelligence that has traditionally suffered from slow training and lack of clear methodology to determine network topology before training starts. Past researchers have used reconfigurable computing as one means of accelerating ANN testing. The goal of this thesis was to learn how recent improvements in the tools and methodologies used in reconfigurable computing have helped advanced the field, and thus, strengthened its applicability towards accelerating ANNs. A new FPGA-based ANN architecture, called RTR-MANN, was created to demonstrate the performance enhancements gained from using current-generation tools and methodologies. RTR-MANN was shown to have an order of magnitude more scalability and functional density compared to older-generation FPGA-based ANN architectures. In addition, use of a new system design methodology (via High-level Language) led to a more intuitive verification / validation phase, which was an order of magnitude faster compared traditional HDL simulators.
Structure, Recognition, and Processing of Cisplatin−DNA Adducts (1999)

ADVERTISEMENT RETURN TO ISSUEPREVArticleNEXTStructure, Recognition, and Processing of Cisplatin−DNA AdductsElizabeth R. Jamieson and Stephen J. LippardView Author Information Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Cite this: Chem. Rev. 1999, 99, 9, 2467–2498Publication Date (Web):August 14, 1999Publication History Received29 April 1999Published online14 August 1999Published inissue 8 September 1999https://pubs.acs.org/doi/10.1021/cr980421nhttps://doi.org/10.1021/cr980421nresearch-articleACS PublicationsCopyright © 1999 American Chemical SocietyRequest reuse permissionsArticle Views13254Altmetric-Citations2491LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Adducts,Antineoplastic agents,Cells,Genetics,Peptides and proteins Get e-Alerts
A Mutation in Human Immunodeficiency Virus Type 1 Protease, N88S, That Causes In Vitro Hypersensitivity to Amprenavir (2000)

Amprenavir (Agenerase, 141-W94, VX-478) is a human immunodeficiency virus type 1 (HIV-1) protease inhibitor (PRI) recently approved for the treatment of HIV-1 infection in the United States. A major cause of treatment failure is the development of resistance to PRIs. One potential use for amprenavir is as salvage therapy for patients for whom treatment that includes one (or more) of the other four currently approved PRIs-saquinavir, indinavir, ritonavir, and nelfinavir-has failed. We evaluated the cross-resistance to amprenavir of viruses that evolved during treatment with the two most commonly prescribed PRIs, nelfinavir and indinavir. Unexpectedly, a dramatic increase in susceptibility (2.5- to 12. 5-fold) was observed with 20 of 312 (6.4%) patient viruses analyzed. The most pronounced increases in susceptibility were strongly associated with an N88S mutation in protease. All viruses that carried the N88S mutation were hypersensitive to amprenavir. Site-directed mutagenesis studies confirmed the causal role of N88S in determining amprenavir hypersensitivity. The presence of the N88S mutation and associated amprenavir hypersensitivity may be useful in predicting an improved clinical response to amprenavir salvage therapy.
Second-Order Zeeman Frequency Shift in the Optically Pumped Cesium Beam Frequency Standard with a Dual Servo System (1999)

The second-order Zeeman effect produces the largest frequency shift among several causes to alter the reference frequency in the optically pumped cesium beam frequency standard. We introduce a novel way to reduce the uncertainties due to the Zeeman effect by adopting a dual servo system, one for stabilizing the current for static magnetic field and the other for normal clock operation. As a result, the combined uncertainty of the second-order Zeeman frequency shift is reduced to 3.2 ×10 -15 , which is smaller by one order of magnitude than that without the servo system.
The overexpression and complete amino acid sequence of Escherichia coli 3-dehydroquinase (1986)

The enzyme 3-dehydroquinase was purified in milligram quantities from an overproducing strain of Escherichia coli. The amino acid sequence was deduced from the nucleotide sequence of the aroD gene and confirmed by determining the amino acid composition of the overproduced enzyme and its N-terminal amino acid sequence. The complete polypeptide chain consists of 240 amino acid residues and has a calculated subunit Mr of 26,377. Transcript mapping revealed that aroD is a typical monocistronic gene.
Animal Models of Dry Eye (2008)

A huge variety of animal models exists, mimicking different pathophysiologic mechanisms which can cause dry eye. The mouse is the model most commonly used to study autoimmune mechanisms, because of the diversity of different knockout and transgenic strains and good availability of antibodies. For studying dry eye signs, rabbit or dog models are more suitable, because they present decreased tear secretion and ocular surface changes, have longer lifespans, and offer better accessibility of the ocular surface. For studying special causes of dry eye, such as defects of neuronal reflex loops, environmental changes, or evaporative dry eye, the model of choice should recapitulate the underlying pathophysiologic mechanism.
Enhancement of Nucleoside Cytotoxicity through Nucleotide Prodrugs (2002)

A common reason for the lack of cytotoxicity of certain nucleosides is thought to be their inability to be initially activated to the monophosphate level by a nucleoside kinase or other activating enzyme. In a search for other nucleosides that might be worthwhile anticancer agents, we have begun to examine the utilization of monophosphate prodrugs in order to explore whether any enhanced cytotoxicity might be found for the prodrugs of candidate nucleosides that have little or no cytotoxicity. To that end, 5'-bis(pivaloyloxymethyl) phosphate prodrugs of two weakly cytotoxic compounds, 8-aza-2'-deoxyadenosine (5) and 8-bromo-2'-deoxyadenosine (9), have been prepared. These prodrugs (8 and 12) were examined for their cytotoxicity in CEM cells and were found to possess significantly enhanced cytotoxicity when compared with the corresponding parent nucleosides. Further cell culture experiments were conducted to gain insight into the mechanisms of cytotoxicity of these two prodrugs, and those data are reported.
Perillyl Alcohol as a Radio-/Chemosensitizer in Malignant Glioma (2003)

The prognosis for patients with malignant glioma has not significantly changed in two decades, despite advances in surgery, radiation, and chemotherapy, emphasizing the growing need for novel approaches to glioma therapy. Perillyl alcohol (POH) is a naturally occurring monoterpene that has been shown to possess chemotherapeutic as well as chemopreventive activity in animal tumor models and is currently in Phase I and Phase II clinical trials. In the present study, we have demonstrated that POH is an effective radiosensitizer at clinically relevant doses of radiation using established glioma cell lines. POH caused a transient arrest in the G2/M phase of the cell cycle and induced apoptosis in glioma cells. POH treatment sensitized glioma cells to Fas-mediated apoptosis, which was further augmented in the presence of ionizing radiation and abrogated in the presence of antagonistic antibody. POH-induced radiosensitization was partially inhibited in glioma cells expressing dominant negative Fas-associated death domain and completely inhibited in glioma cells overexpressing the cytokine response modifier A. In addition, POH treatment resulted in a dose-dependent sensitization to cisplatin and doxorubicin induced cytotoxicity in glioma cells, highlighting its usefulness as a potent radio/chemosensitizer in the treatment of malignant glioma.
Pathogen Webs in Collapsing Honey Bee Colonies (2012)

Recent losses in honey bee colonies are unusual in their severity, geographical distribution, and, in some cases, failure to present recognized characteristics of known disease. Domesticated honey bees face numerous pests and pathogens, tempting hypotheses that colony collapses arise from exposure to new or resurgent pathogens. Here we explore the incidence and abundance of currently known honey bee pathogens in colonies suffering from Colony Collapse Disorder (CCD), otherwise weak colonies, and strong colonies from across the United States. Although pathogen identities differed between the eastern and western United States, there was a greater incidence and abundance of pathogens in CCD colonies. Pathogen loads were highly covariant in CCD but not control hives, suggesting that CCD colonies rapidly become susceptible to a diverse set of pathogens, or that co-infections can act synergistically to produce the rapid depletion of workers that characterizes the disorder. We also tested workers from a CCD-free apiary to confirm that significant positive correlations among pathogen loads can develop at the level of individual bees and not merely as a secondary effect of CCD. This observation and other recent data highlight pathogen interactions as important components of bee disease. Finally, we used deep RNA sequencing to further characterize microbial diversity in CCD and non-CCD hives. We identified novel strains of the recently described Lake Sinai viruses (LSV) and found evidence of a shift in gut bacterial composition that may be a biomarker of CCD. The results are discussed with respect to host-parasite interactions and other environmental stressors of honey bees.
Investigation of Standing-Wave Formation in a Human Skull for a Clinical Prototype of a Large-Aperture, Transcranial MR-Guided Focused Ultrasound (MRgFUS) Phased Array: An Experimental and Simulation Study (2011)

Standing-wave formation in an ex vivo human skull was investigated using a clinical prototype of a 30-cm diameter with 15-cm radius of curvature, low-frequency (230 kHz), hemispherical transcranial magnetic resonance-guided focused ultrasound phased array. Experimental and simulation studies were conducted with changing aperture size and f -number configurations of the phased array and qualitatively and quantitatively examined the acoustic pressure variation at the focus due to standing waves. The results demonstrated that the nodes and antinodes of standing wave produced by the small-aperture array were clearly seen at approximately every 3 mm. The effect of the standing wave became more pronounced as the focus was moved closer to skull base. However, a sharp focus was seen for the full array, and there was no such standing-wave pattern in the acoustic plane or near the skull base. This study showed that the fluctuation pressure amplitude would be greatly reduced by using a large-scale, hemispherical phased array with a low f-number.
Nurr1 regulates RET expression in dopamine neurons of adult rat midbrain (2010)

Genesis of midbrain dopamine (DA) neurons depends on Nurr1, a nuclear receptor expressed during development and adulthood in these neurons. Nurr1 is required for the expression of genes of dopaminergic phenotype such as tyrosine hydroxylase and DA transporter. The expression of the tyrosine kinase receptor RET also depends on Nurr1 during development. However, it is unknown whether RET expression is regulated by Nurr1 during adulthood, and the mechanism by which Nurr1 regulates RET expression. Using an adeno-associated vector-delivered anti-Nurr1 ribozyme, we knocked-down Nurr1 expression unilaterally in the substantia nigra (SN) of adult rats. Animals injected with the ribozyme displayed a 57.3% decrease in Nurr1 mRNA in the SN accompanied by decreased DA extracellular levels in the striatum. RET mRNA in the injected SN and RET protein in the ipsilateral striatum decreased 76.9% and 47%, respectively. Tyrosine hydroxylase and DA transporter mRNA did not change in Nurr1 knocked-down SN. Nurr1 induced the transcription of the human RET promoter in cell type and concentration-dependent manner. Nurr1 induction of RET promoter is independent of NBRE elements. These results show that the expression of RET in rat adult SN is regulated by Nurr1 and suggest that RET is a transcriptional target of this nuclear receptor.
Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial (2011)

This trial evaluated the feasibility and efficacy of the infusion of mesenchymal stem cells expanded using human serum for the treatment of refractory acute or chronic graft-versus-host disease. Twenty-eight expansions were started. In 22, a minimum of more than 1 x 10⁶ mesenchymal stem cells/kg were obtained after a median of 26 days; this threshold was not obtained in the remaining cases. Ten patients received cells for the treatment of refractory or relapsed acute graft-versus-host disease and 8 for chronic disease. One patient treated for acute graft-versus-host disease obtained a complete response, 6 had a partial response and 3 did not respond. One of the chronic patients achieved complete remision, 3 a partial response, and 4 did not respond. The current study supports the use of this approach in less heavily treated patients for both acute and chronic graft-versus-host disease. The trial has been registered at ClinicalTrials.gov: identifier NCT00447460.
High Resolution 3D X-Ray Diffraction Microscopy (2002)

We have imaged a 2D buried Ni nanostructure at 8 nm resolution using coherent x-ray diffraction and the oversampling phasing method. By employing a 3D imaging reconstruction algorithm, for the first time we have experimentally determined the 3D structure of a noncrystalline nanostructured material at 50 nm resolution. The 2D and 3D imaging resolution is currently limited by the exposure time and the computing power, while the ultimate resolution is limited by the x-ray wavelengths. We believe these results pave the way for the development of atomic resolution 3D x-ray diffraction microscopy.
On-chip delay measurement circuit (2012)

A novel On-chip delay measurement circuit is presented which is suitable for wide applications involving on-chip measurements, monitoring and process compensation. The circuit is based upon multiple characterization units consisting of ring oscillator, latches and counter. The delay unit used in ring oscillator defines the measurement resolution for the characterization unit. Each characterization unit has different delay cell with delay varying by few Pico-seconds (~1 to 5 picoseconds) with other one, which helps in increasing the resolution. All units give values based on their delay units and collectively all values forms a statistical space whose median gives the pulse width value. In this way, the circuit overcomes the limitations of earlier proposed on-chip measurement systems by offering high accuracy, high resolution and wide range of measurement using very few components. Silicon results on CMOS 40nm technology node for characterization of memory access time based upon proposed system are also presented.
Named organic reactions (1999)

Partial table of contents: Aldol Reaction. Benzoin Condensation. 1,3-Dipolar Cycloaddition. Diazo Coupling. Friedel-Crafts Alkylation. Grignard Reaction. Haloform Reaction. Malonic Ester Synthesis. Ozonolysis. Perkin Reaction. Sharpless Epoxidation. Vinylcyclopropane Rearrangement. Wittig Reaction. Index.
Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study. (1981)

The effect of once daily dosage of carbamazepine on fit frequency, electroencephalogram (EEG), behaviour and 24-hour drug levels were compared with those following 2 to 3 divided daily doses treatment. The 14 male epileptics, aged 16 to 18 years, who were studied had already been receiving carbamazepine for an average period of 2.5 years in combination with other anti-epileptic drugs. In this investigation, these patients received their usual daily dose (mean dose 13.9 mg/dg) of carbamazepine in 3-time, twice and once daily regimens. Each treatment period lasted for 4 weeks. Plasma concentrations of carbamazepine and its epoxide metabolite remained within the therapeutic range during the three treatment periods, but the area under the curves were greater during once daily medication. There was also slight decrease in the plasma sodium valproate concentration during the once daily regimen, but the concentrations of other concomitant medication remained unchanged. No significant changes in fit frequency and behaviour were observed athe area under the curves were greater during once daily medication. There was also slight decrease in the plasma sodium valproate concentration during the once daily regimen, but the concentrations of other concomitant medication remained unchanged. No significant changes in fit frequency and behaviour were observed athe area under the curves were greater during once daily medication. There was also slight decrease in the plasma sodium valproate concentration during the once daily regimen, but the concentrations of other concomitant medication remained unchanged. No significant changes in fit frequency and behaviour were observed and none of these patients suffered from any side-effects or toxic effects during once daily medication. EEG revealed a slight increase in abnormality during twice daily medication, but no further deterioration was seen during one daily treatment. In view of this observation, carbamazepine is probably effective as a single daily dose, but further long-term controlled clinical trial in necessary.
Let-go currents and voltages (1956)

Let-go current curves are presented for commercial 60-cycle a-c and for direct current. New data are presented which confirm previously published let-go current curves for direct currents having various amounts of a-c ripple content, together with new data for 60-cycle a-c let-go voltages. The voltage analysis is extended to cover direct current, thus rounding out the subject of let-go hazards. Reasonably safe let-go currents and voltages are computed from tests made on substantial numbers of normal, healthy individuals. It is believed that reasonably safe limits may be based on the predicted response for 99 1/2 per cent of a large group. The probability of receiving dangerous electric shocks must be anticipated, and preventive measures must be considered vital ingredients in the design of machines, in the framing of operating instructions, and in work procedures.